By Daniel J. DeNoon
WebMD Health News
Reviewed by Louise Chang, MD
High blood levels of a plaque peptide may predict Alzheimer's disease in elderly people.
The finding comes from a study of 1,125 people who were in their late 70s when their blood was first tested. Four and a half years later, 104 of them had Alzheimer's disease.
Those with the highest blood levels of A-beta 42, a major component of the plaque that clogs the brains of Alzheimer's patients, were far more likely to get Alzheimer's than were those with the lowest A-beta 42 levels.
"Compared with individuals with low [blood] A-beta 42 levels at baseline, those with high A-beta 42 levels had more than a threefold increased risk of developing Alzheimer's disease over an average of...read the whole article
Susan Berg, dementia expert, shares practical help for caregivers of those with dementia including easy to do activities
Friday, September 12, 2008
Wednesday, September 10, 2008
Expertise counts with deep brain stimulation
Chicago Tribune
Judith Graham
--------------------------------------------------------------------------------
Expertise counts with deep brain stimulation
With deep brain stimulation, as with many complicated medical procedures, it’s important to evaluate the expertise of physicians and hospitals before signing up as a patient.
This expensive treatment—it costs up to $150,000 or more--is now being offered by more than 300 medical centers across the U.S.
In a story today, I examine how physicians and scientists are exploring the use of the therapy for a variety of neurological and psychological conditions.
Currently, deep brain stimulation is approved by the Food and Drug Administration only for use in patients with Parkinson’s disease and essential tremor. Patients with dystonia can also get the treatment under a FDA humanitarian device exemption.
Hospitals’ experience with this therapy varies widely. Some centers treat up to 100 or more patients a year; others treat only a handful.
Some medical centers do extraordinarily careful workups to identify patients most likely to benefit from deep brain stimulation; others don’t.
Not all physicians carefully monitor patients who’ve had the procedure to make sure they’re deriving the maximum possible benefit.
And not all surgeons are expert at placing electrodes at exactly the right spot in the brains of patients. If the electrode is 1 or 2 millimeters off target.....read the rest of the story and comments
Judith Graham
--------------------------------------------------------------------------------
Expertise counts with deep brain stimulation
With deep brain stimulation, as with many complicated medical procedures, it’s important to evaluate the expertise of physicians and hospitals before signing up as a patient.
This expensive treatment—it costs up to $150,000 or more--is now being offered by more than 300 medical centers across the U.S.
In a story today, I examine how physicians and scientists are exploring the use of the therapy for a variety of neurological and psychological conditions.
Currently, deep brain stimulation is approved by the Food and Drug Administration only for use in patients with Parkinson’s disease and essential tremor. Patients with dystonia can also get the treatment under a FDA humanitarian device exemption.
Hospitals’ experience with this therapy varies widely. Some centers treat up to 100 or more patients a year; others treat only a handful.
Some medical centers do extraordinarily careful workups to identify patients most likely to benefit from deep brain stimulation; others don’t.
Not all physicians carefully monitor patients who’ve had the procedure to make sure they’re deriving the maximum possible benefit.
And not all surgeons are expert at placing electrodes at exactly the right spot in the brains of patients. If the electrode is 1 or 2 millimeters off target.....read the rest of the story and comments
Monday, September 8, 2008
Deep Brain Stimulation Inexplicably Restores Vivid Memories
Natural News.com
Scientists searching for a way to suppress appetite accidentally discovered a way to trigger vivid memories. The researchers hope to develop the technique into a treatment for Alzheimer's disease, according to a study published in Annals of Neurology.
Researchers at the Toronto Western Hospital in Ontario, Canada, were operating on an obese man in an attempt to find a part of the brain that could suppress the appetite when stimulated electrically. When the scientists stimulated the hypothalamus, which has been associated with hunger, the man suddenly experienced a vivid memory from 30 years before.
"He reported the experience of.....read the whole article
Scientists searching for a way to suppress appetite accidentally discovered a way to trigger vivid memories. The researchers hope to develop the technique into a treatment for Alzheimer's disease, according to a study published in Annals of Neurology.
Researchers at the Toronto Western Hospital in Ontario, Canada, were operating on an obese man in an attempt to find a part of the brain that could suppress the appetite when stimulated electrically. When the scientists stimulated the hypothalamus, which has been associated with hunger, the man suddenly experienced a vivid memory from 30 years before.
"He reported the experience of.....read the whole article
Sunday, September 7, 2008
Brain Cells 'Supercharged' To Attack Plaques That Cause Alzheimer’s Disease
Science Daily
Researchers at the University of British Columbia have discovered a new method for developing treatments for Alzheimer’s Disease (AD). They have shown that by stimulating a brain cell called a microglia the cells will partially engulf the senile plaques which are abundant in post mortem AD brain.
The study, published in the Journal of Alzheimer’s Disease, marks the first time that this phenomenon, believed to take place in living brain, has been duplicated in the laboratory. It offers a new....... read the whole story by clicking here
Researchers at the University of British Columbia have discovered a new method for developing treatments for Alzheimer’s Disease (AD). They have shown that by stimulating a brain cell called a microglia the cells will partially engulf the senile plaques which are abundant in post mortem AD brain.
The study, published in the Journal of Alzheimer’s Disease, marks the first time that this phenomenon, believed to take place in living brain, has been duplicated in the laboratory. It offers a new....... read the whole story by clicking here
Saturday, September 6, 2008
Exercise can slow memory loss in progress
Here is a great dementia resource for caregivers and healthcare professinals,
Here is information on being the best caregiver you can be
Here are more interesting dementiaarticles and activities,
ABC7Chicago
Now a new study in the Journal of the American Medical Association finds exercise can even slow down memory loss in those that are already having difficulty.(Alzheimers)
Doctors followed 170 seniors with mild memory problems. Half were encouraged to exercise a couple hours per week while the other half kept to their normal activities.
Most of the participants in the exercise program chose walking, and after six months they had .... read more of Exercise can slow memory loss in progress
Here is information on being the best caregiver you can be
Here are more interesting dementiaarticles and activities,
ABC7Chicago
Now a new study in the Journal of the American Medical Association finds exercise can even slow down memory loss in those that are already having difficulty.(Alzheimers)
Doctors followed 170 seniors with mild memory problems. Half were encouraged to exercise a couple hours per week while the other half kept to their normal activities.
Most of the participants in the exercise program chose walking, and after six months they had .... read more of Exercise can slow memory loss in progress
Thursday, September 4, 2008
Fatal Protein Interactions May Explain Neurological Diseases
ScienceDaily (Sep. 3, 2008) — In a collaborative study at the University of California, San Diego, investigators from neurosciences, chemistry and medicine, as well as the San Diego Supercomputer Center (SDSC) have investigated how proteins involved in neurodegenerative diseases such as Alzheimer's and Parkinson's disease interact to form unique complexes. Their findings explain why Alzheimer's patients might develop Parkinson's, and vice versa.
The new and unique molecular structures they discovered can now be used to model and develop new drugs for these devastating neurological diseases. Their findings will be published in the September 3 issue of Public....
read the whole article
The new and unique molecular structures they discovered can now be used to model and develop new drugs for these devastating neurological diseases. Their findings will be published in the September 3 issue of Public....
read the whole article
Monday, September 1, 2008
Brain injury study adds to Alzheimer's enigma
CHICAGO (Reuters) – Levels of a protein linked with Alzheimer's disease rise as people recover from brain injuries – a surprising finding that may help explain why injuries boost the risk of developing the disease, U.S. and Italian researchers said on Thursday. Researchers at Washington University in St. Louis and the University of Milan did hour-by-hour measurements of the protein amyloid beta in 18 patients with severe brain injury as they were coming out of a coma
To read more heath news click here
To read the whole story by Julie Steenhuysen click here
To read more heath news click here
To read the whole story by Julie Steenhuysen click here
Subscribe to:
Posts (Atom)

